Related references
Note: Only part of the references are listed.Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model
Kohei Omachi et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)
Podocyte p53 Limits the Severity of Experimental Alport Syndrome
Ryosuke Fukuda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
Sonja M. Woermann et al.
GASTROENTEROLOGY (2016)
Beyond EMT: Epithelial STAT3 as a Central Regulator of Fibrogenesis
Jeremy S. Duffield
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Stat3 Controls Tubulointerstitial Communication during CKD
Frank Bienaime et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease
Naoki Nakagawa et al.
JCI INSIGHT (2016)
Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice
Lindsay J. Edwards et al.
CLINICAL IMMUNOLOGY (2015)
Superovulation Using the Combined Administration of Inhibin Antiserum and Equine Chorionic Gonadotropin Increases the Number of Ovulated Oocytes in C57BL/6 Female Mice
Toru Takeo et al.
PLOS ONE (2015)
The Transcription Factor MEF/Elf4 Is Dually Modulated by p53-MDM2 Axis and MEF-MDM2 Autoregulatory Mechanism
Mary Ann Suico et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment
Judy Savige
JOURNAL OF PHYSIOLOGY-LONDON (2014)
Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 Dysregulation in lungs of fibrosis-resistant BALB/c mice
Steven Wong et al.
LABORATORY INVESTIGATION (2014)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
Xiao-Ming Meng et al.
CLINICAL SCIENCE (2013)
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
Oliver Gross et al.
KIDNEY INTERNATIONAL (2012)
Mild Electrical Stimulation and Heat Shock Ameliorates Progressive Proteinuria and Renal Inflammation in Mouse Model of Alport Syndrome
Tomoaki Koga et al.
PLOS ONE (2012)
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
KIDNEY INTERNATIONAL (2010)
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Ting-Chi Lu et al.
KIDNEY INTERNATIONAL (2009)
Treatment of Alport syndrome: beyond animal models
Oliver Gross et al.
KIDNEY INTERNATIONAL (2009)
Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease
Daniel T. Meehan et al.
KIDNEY INTERNATIONAL (2009)
STAT3: An important regulator of multiple cytokine functions
Stanislaw M. Stepkowski et al.
TRANSPLANTATION (2008)
Inhibition of JAK/STAT signaling ameliorates mice experimental nephrotic syndrome
Rong Li et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease
Michael Zeisberg et al.
PLOS MEDICINE (2006)
Role of Stat3 in regulating p53 expression and function
GL Niu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mouse model of X-linked Alport syndrome
MN Rheault et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
D de Zeeuw et al.
KIDNEY INTERNATIONAL (2004)
Alport's syndrome, Goodpasture's syndrome, and type IV collagen
BG Hudson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome
O Gross et al.
KIDNEY INTERNATIONAL (2003)
p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3
J Lin et al.
ONCOGENE (2002)
Global gene expression analysis reveals a role for the α1 integrin in renal pathogenesis
NS Sampson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
